STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced a leadership ...

AUSTIN, Texas — Children in public schools in Texas could be taking a redesigned standardized test as early as next year under a proposal filed in the House on Thursday. House Bill 4, by State Rep.

“It is shedding some of the challenges with our current STAAR test and moving to something that makes sure students have more time to develop a love of learning and teachers have the information ...

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of STAAR Surgical Company ("Staar" or "the Company") (NASDAQ ...

Hopper, in a post sharing the news of the filing of the bill on social media, also called for discussions about ending the STAAR test, a standardized exam given to students in grades 3-8 and high ...

AUSTIN, Texas — A North Texas lawmaker filed a bill Tuesday that would eliminate key functions of public education in the Lone Star State, including the Texas Education Agency and the STAAR test.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

STAAR Surgical's Q4 results were severely impacted by lower demand and high inventory levels in China. Global growth ex-China was 17% in Q4 and is expected to remain strong at 12% for FY25, with ...

Jefferies downgraded Staar Surgical (STAA) to Hold from Buy with a price target of $18, down from $60, following the company’s Q4 report and initial 2025 guidance. The outlook reflects a ...

Capital Expenditures: Expected to be approximately $15 million for fiscal 2025. Staar Surgical Co (NASDAQ:STAA) reported strong growth in ICL sales outside of China, with a 17% increase in the ...

(RTTNews) - Shares of STAAR Surgical Company (STAA) are down over 37% in Wednesday's premarket trading after the company reported its fourth-quarter results for fiscal year 2024, highlighting the ...